AzTrials
AzTrials

HalitosisNCT04905940

Evaluation of Clinical and Cost-effectiveness of Different Mouthwashes on Controlling Halitosis Among a Group of Egyptian Children

A study testing Turmeric mouthwash in people with Halitosis, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To evaluate the clinical and cost-effectiveness of mouthwash containing Curcuma longa (Turmeric extract) versus mouthwash containing essential oils and Placebo mouthwash on controlling Halitosis among a group of Egyptian children. Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Halitosis
What is being tested?
Turmeric mouthwash
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
No sites listed yet
Study dates
1 Aug 2022to 1 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 8-12 years old.
  • Cooperative children.
  • Both genders.
  • Medically free to exclude systemic cause of halitosis.
  • Bad breath

Who cannot join

  • Children using any other oral hygiene aid other than routine teeth brushing.
  • Children with a known history of allergy to any mouthwash or drug.
  • Parents refuse to participate in the trial.
  • Treatment by antibiotic within one month before the trial(Pham \& Nguyen, 2018).
  • Abscess, draining sinus, cellulitis, or other conditions requiring emergency dental treatment.
  • Children using fixed or removable orthodontic appliances or dentures.
  • Children with a history of deleterious oral habits of mouth breathing.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Evaluation of Cost-Effectiveness And Clinical Effectiveness of Mouthwash Containing Curcuma Longa Versus Essential Oil and A Placebo Mouthwash on Controlling Halitosis Among Egyptian Children: A Randomized Clinical Trial

To evaluate the clinical and cost-effectiveness of mouthwash containing Curcuma longa (Turmeric extract) versus mouthwash containing essential oils and Placebo mouthwash on controlling Halitosis among a group of Egyptian children.

Read the detailed description

For both interventions:

  1. Eligibility screen and patient selection according to the inclusion and exclusion criteria.
  2. Readings for halitosis will be recorded using Tanita HC-312F Fitscan Portable Breath Checker (Tanita Corporation, Japan) that shows red, yellow and green colors indicating halitosis degree.
  • Green color=no odour
  • Yellow color=moderate odour
  • Red color=intense odour Children with yellow or red colored results will be included.
  1. Participants will be provided with information regarding the risks and benefit of the study and written informed consent will be obtained.
  2. Intra and extra-oral examinations and Baseline records photographs, caries assessment by using DMF, gingival condition assessment using Simplified oral hygiene index and personal data collection.
  3. Participating children will be offered a full mouth restorative treatment, if needed, before starting the trial to exclude that halitosis comes from food impaction in carious teeth.
  4. In another visit, after the full mouth rehabilitation, readings for halitosis will be re-recorded using color coded Tanita HC-312F Fitscan Portable Breath Checker (Tanita corporate, Japan). Patients who will get green colored result will be excluded from the study as the cause of halitosis in those patients would be food impaction in carious teeth.
  5. Allocation of the participants who will score more than 2 into either one of three groups; A, B or C. i. A for Experimental group (Turmeric mouthwash) ii. B for first comparator (Essential oil mouthwash) iii. C for second comparator (Placebo) Allocation will be concealed by withdrawing a sealed opaque envelope containing four times folded paper containing the type of mouth wash that will be used. This will decrease performance bias as the operator will not know the group of the participant until taking the score of the patients and finishing the restorative treatment. Blinding of the operator will not be needed as the readings will be objective and recorded using the device (Tanita device) not by the operator (organoleptic method).
  6. All mouth rinse samples (experimental and comparators 1\&2) will be put into identical white opaque plastic bottles labelled with the codes A, B or C for the blinding of the participant. Group A: The experimental sample is a Turmeric mouthwash which will be prepared by dissolving 10 mg of Turmeric extract in 100 mL of distilled water and 0.005% of flavouring agent peppermint oil (Sharma, 2016). Group B: The first comparator will be the commercial Miswak Listerine mouthwash. Group C: The second comparator will be a placebo mouthwash and will be prepared with peppermint oil and distilled water; essentially the same contents as those in the experimental mouthwash except for the turmeric powder.
  7. Every participant will use 2 mouthwash bottles of the same group label that they were allocated to. The first bottle according to their allocation. Patients will be given standard written oral hygiene instructions and mouth washing instructions to rinse twice daily with 10 ml for 1 minute under their parents" supervision for two weeks.
  8. The first follow up visit after two weeks, the halitosis score will be recorded by using the Tanita device for numerical record and by asking the parent if there is a bad odour or not. Patients then will be instructed to stop rinsing for the next two weeks while maintaining other oral hygiene instructions.
  9. The second follow-up visit after 4 weeks, patients will be given the second bottle and instructed to rinse twice daily with 10 ml for another two weeks.
  10. The last follow up visit will be after 6 weeks and the final Halitosis score will be recorded.
Conditions
Halitosis
Being tested
Turmeric mouthwash
Medical subject headings
Halitosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Turmeric mouthwashDrug

    Turmeric mouthwash evaluation in controlling halitosis

Study groups in NCT04905940
Study groupRoleWhat they receive
Turmeric mouthwashExperimentalEvaluation of cost-effectiveness of turmeric mouthwash in controlling halitosis
Receives: Drug: Turmeric mouthwash
Essential oil mouthwashActive comparatorEvaluation of cost-effectiveness of essential oil mouthwash in controlling halitosis
Receives: Drug: Turmeric mouthwash
Placebo mouthwashPlacebo comparatorEvaluation of cost-effectiveness of placebo mouthwash in controlling halitosis
Receives: Drug: Turmeric mouthwash

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Questionnaire for Patient related side effects

    the measuring unit will be binary (yes/no) from the parent and child.

    While using the mouthwash:

    1. Is the Child's quality of life changed for the better?
    2. Acceptance and safety of the mouth wash

    Measured: 45 days

Secondary outcomes (1)
  1. Cost-effectiveness

    Economic and Clinical effectiveness of turmeric mouthwash

    Cost effectiveness will be measured according to ICER (Incremental cost-effectiveness ratio)

    Measured: 45 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2021
  2. Study start1 Aug 2022 (estimated)
  3. Primary completion1 Dec 2022 (estimated)
  4. Study completion1 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04905940
Sponsor's protocol ID
14422019461401
Status last verified
Jul 2022
First submitted
19 May 2021
Last updated
27 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Turmeric mouthwash in people with Halitosis, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Eman M Elsaeed, B.Sc (+201000994721, eman.elsaeed@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Questionnaire for Patient related side effects (time frame: 45 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in